Literature DB >> 16135206

Effects of pre- versus post-anaesthetic buprenorphine on propofol-anaesthetized rats.

Jacques Penderis1, Robin Jm Franklin.   

Abstract

OBJECTIVE: To compare the effect of pre- versus post-anaesthetic intramuscular (IM) buprenorphine on intermittent intravenous (IV) propofol anaesthesia in rats. ANIMALS: Twenty healthy, adult, female, ex-breeder Sprague-Dawley rats within the mass range 274-379 g.
MATERIALS AND METHODS: Animals were randomly allocated to one of two groups. Group 1 (n = 10) received 9 mug buprenorphine (IM) at the start and group 2 (n = 10) received the same dose buprenorphine at the end of anaesthesia. Five animals from each group (randomly selected) received a standardized 40-minute surgical procedure (procedure 1), the remaining half, a standardized 60-minute surgical procedure (procedure 2). Induction of anaesthesia with 4% isoflurane carried in oxygen was immediately followed by IV propofol (3 mg) and intraperitoneal diazepam (500 microg). Anaesthesia was maintained using periodic IV propofol (500 microg) injected through an indwelling tail vein cannula, by an operator ignorant of the buprenorphine status. One hour after recovery from anaesthesia, the animals' level of awareness were scored by an observer ignorant of both the buprenorphine status and the total propofol dose administered.
RESULTS: Buprenorphine administration at the start of anaesthesia versus administration at the end resulted in a significant reduction in the total per-kilogram requirement for propofol from a mean of 24 mg kg(-1) (+/-2.5 mg kg(-1), n = 5) to 5.5 mg kg(-1) (+/-1.1 mg kg(-1), n = 5) for procedure 1, and from a mean of 30 mg kg(-1) (+/-1.2 mg(-1), n = 5) to 16 mg kg(-1) (+/-1.0 mg kg(-1), n = 5) in procedure 2. Animals receiving buprenorphine at the start of anaesthesia demonstrated a higher level of awareness 1 hour after cessation of anaesthesia. No adverse effects were evident in either group 24 hours after recovery.
CONCLUSIONS: Buprenorphine administration at the start of periodic IV propofol anaesthesia in rats resulted in a significant reduction in the total propofol requirement and significantly improved the 1-hour post-anaesthesia recovery score. Clinical relevance Besides the ethical advantage of pre-emptive analgesia, pre-anaesthetic medication with buprenorphine in rats significantly reduces the total propofol requirements for surgical anaesthesia and in this study was found to be a safe and effective method of anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135206     DOI: 10.1111/j.1467-2995.2005.00183.x

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  5 in total

1.  Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: effects on body weight, locomotor activity, and hemodynamic parameters.

Authors:  Stephane L Bourque; Michael A Adams; Kanji Nakatsu; Andrew Winterborn
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

2.  Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL/6J mice.

Authors:  Jenelle M Izer; Tiffany L Whitcomb; Ronald P Wilson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

3.  Pharmacokinetics of Sustained-release and Extended-release Buprenorphine in Mice after Surgical Catheterization.

Authors:  Marissa Saenz; Elizabeth A Bloom-Saldana; Tim Synold; Richard W Ermel; Patrick T Fueger; James B Finlay
Journal:  J Am Assoc Lab Anim Sci       Date:  2022-08-25       Impact factor: 1.706

4.  Clinical Management of Pain in Rodents.

Authors:  Patricia L Foley; Lon V Kendall; Patricia V Turner
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

5.  Propofol produces preventive analgesia via GluN2B-containing NMDA Receptor/ERK1/2 Signaling Pathway in a rat model of inflammatory pain.

Authors:  Qiu Qiu; Liting Sun; Xiao-Min Wang; Amy C Y Lo; Kar Lok Wong; Pan Gu; Sau Ching Stanley Wong; Chi Wai Cheung
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.